Collegium Pharmaceutical (COLL) Tax Rate Growth (3y) (2023 - 2026)
Analysis
Collegium Pharmaceutical (COLL) Tax Rate Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Collegium Pharmaceutical | 753.09 Mn | 603.77 Mn | 110.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,814.00 |
| Mar 31, 2026 | 2,190.00 |
| Dec 31, 2025 | 3,398.00 |
| Sep 30, 2025 | -4,062.00 |
| Jun 30, 2025 | 772.00 |
| Mar 31, 2025 | 508.00 |
| Dec 31, 2024 | -820.00 |
| Sep 30, 2024 | 2,912.00 |
| Jun 30, 2024 | 59,537.00 |
| Mar 31, 2024 | 2,554.00 |
| Dec 31, 2023 | 2,743.00 |
| Sep 30, 2023 | 2,589.00 |
| Jun 30, 2023 | 2,395.00 |
| Mar 31, 2023 | -5,392.00 |